BioAssays is granted funding by the Community of Madrid to host its third Industrial PhD Project
12 December 2020For the third consecutive year, BioAssays has passed the selection process of the Community of Madrid for the granting of companies hosting Industrial...
BioAssays is granted funding from “Torres-Quevedo” Program to hire a Biotech PhD
14 September 2020At BioAssays we are very interested in attracting talent and experience in Biotechnology, so we have requested funding from “Torres-Quevedo” Program, ...
Arquimea Medical (Alianza Covid-19) launches a blood sampling system compatible with ELISA for COVID-19
20 July 2020Arquimea Medical, “Alianza Covid-19” leader, launches an innovative system for the collection and storage of blood samples validated by BioAssays, 100...
BioAssays is certified according to the ISO 9001:2015 Quality Seal
13 July 2020Quality of our services is crucial for BioAssays, that is why we wanted to be certified with the ISO 9001:2015 Quality Seal, which certifies that our ...
BioAssays participates in the European “EUvsVirus” Hackathon
25 April 2020Alongside more than 21.000 participants across Europe, BioAssays has collaborated in the “EUvsVirus” Hackathon, a meeting point to connect scientists,...
BioAssays takes part of Alianza Covid-19
1 April 2020Alianza Covid-19 is a consortium that brings together biotechnology companies and certified laboratories, including BioAssays, and offers an integrate...
BioAssays submits a proposal for new ISCIII Covid-19 call
19 March 2020ISCIII (Institute of Health Carlos III), under Spanish Ministry of Science and Innovation, has launched an extraordinary funding call for proposals on...
BioAssays submits a proposal for new IMI2 Covid-19 call (Horizon 2020)
4 March 2020Committed to the fight against the emerging SARS-CoV-2 coronavirus, responsible for the ongoing pandemic of Covid-19, designated Public Health Emergen...
BioAssays rewarded by Youth Guarantee initiative from the Community of Madrid
30 January 2020Thanks to BioAssays trust in youth talent, hiring young staff is an essential part of our employment strategy. The Consejería de Economía, Empleo y Co...
BioAssays open its new laboratory
1 October 2019At BioAssays, we are proud to announce the opening of our new laboratory at the Madrid Science Park (PCM). A new, more spacious and more equipped labo...
HORIZON 2020 COLABORATION
24 July 2019The European Framework Programme call for Research and Innovation, Horizon 2020, is open. BioAssays is interested in participating as a partner in Eur...
BioAssays renews the Innovative SME Seal
4 December 2018BioAssays has renewed for the next 3 years the Innovative SME Seal awarded for the first time in 2015 by the General Directorate of Innovation and Com...
BioAssays funded by CDTI under Europenan EraNet Co-Biotech programme.
16 September 2018BioAssays increases its R+D+i lines with Hombiocat project, focused on the fabrication of biocatalysts for renewable feedstocks exploitation.BioAssays...
ERANET CO-BIOTECH 2017 Call
31 October 2017Thanks to the EraNet Co-Biotech programme of the European Horizon 2020, BioAssays increases its R+D+i with the development of biocatalysts for the pro...
NEOTEC 2016 Call
6 June 2017BioAssays strengthens its R+D+i in animal vaccines development through the “2016 NEOTEC” call.BioAssays has been funded by the Centro de Desarrollo Te...
EMPLEA 2014 call
1 November 2014BioAssays strengthens its R+D+i in Molecular Diagnosis of viral infections through the EMPLEA 2014 call.BioAssays has been funded by the Ministerio de...
BioAssays opens its first laboratory
1 June 2013BioAssays opens its first Molecular and Cell Biology laboratory at Parque Científico de Madrid (www.FPCM.es).